Related Experiment Videos
[14C-pentacin pharmacokinetics in percutaneous uptake]
Farmakologiia I Toksikologiia
|November 1, 1983
Summary
This study tracked the absorption and excretion of a calcium-based chelator, Na3Ca-14C-diethylene triaminopentacetic acid, applied topically. Researchers quantified its distribution in rat tissues and urine over time.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Toxicology and Environmental Health
Context:
- Investigating percutaneous absorption of chelating agents.
- Evaluating the influence of formulation vehicles (DMSO vs. aqueous solution) on drug delivery.
- Assessing the systemic distribution and elimination pathways of Na3Ca-DTPA.
Purpose:
- To quantitatively elucidate the mechanisms governing the percutaneous administration and subsequent elimination of Na3Ca-DTPA.
- To determine the time-dependent distribution of Na3Ca-DTPA in various rat tissues and excreta.
- To compare the pharmacokinetic profiles of Na3Ca-DTPA when applied in different solvent systems.
Summary:
- The study monitored the disposition of radiolabeled Na3Ca-DTPA (diethylene triaminopentacetic acid) after topical application to rat skin.
- Quantitative data were collected on the drug's presence in skin, blood, skeleton, liver, kidneys, and urine over a defined period.
- Formulation effects were implicitly studied by comparing absorption and elimination in 50% dimethyl sulfoxide versus aqueous solutions.
Impact:
- Provides crucial data for understanding the systemic exposure following topical application of Na3Ca-DTPA.
- Informs the development of optimized formulations for enhanced percutaneous delivery or minimized systemic absorption.
- Contributes to the risk assessment of topical chelating agents by detailing their absorption, distribution, metabolism, and excretion (ADME) profiles.